Loading resource…

Isaac Magulu Kimbowa
The document defines diabetes mellitus and distinguishes between type 1 and type 2 disease, describing their pathophysiology and clinical manifestations. It details the mechanisms, efficacy, and adverse effects of sulfonylureas, as well as newer drug classes such as GLP‑1 agonists and DPP‑4 inhibitors. Diagnostic criteria, including glucose tolerance testing, are also presented. Learning objectives guide the reader to understand key terms, disease mechanisms, and pharmacologic differences among oral and parenteral agents.
No account needed